Email
Print
Market Overview:
The Intracardiac Echocardiography Market size is estimated to reach $997Million by 2031, growing at a CAGR of 10.2% during the forecast period 2025-2031, according to a recent report published by IndustryARC, titled, “Intracardiac Echocardiography Market – By Product Type (Intracardiac Echocardiography Systems, Intracardiac Echocardiography Catheters and Accessories), By Application (Electrophysiology, Left Atrial Appendage Closure, Transcatheter Aortic Valve Implantation, Mitra Clip Implantation and Mitral Valvuloplasty, and Others), By End-User (Hospitals, Cardiology Clinics, Diagnostic Centers, Independent Cath Labs and Others), By Geography - Opportunity Analysis & Industry Forecast, 2025-2031The increasing demand for minimally invasive procedures, coupled with advancements in AI-enhanced imaging, is significantly driving the growth of the market. Additionally, the integration of AI and machine learning into ultrasound technology is fueling new opportunities, improving diagnostic accuracy and workflow efficiency for the ICE Market during the forecast period.
North America Dominated the Market in 2024:
North America held the largest share of 36% of the Intracardiac Echocardiography Market in 2024. The region is home to numerous leading healthcare institutions that contribute significantly to the market’s dominance. For instance, in November 2024, St. Mary’s Hospital in Centralia, IL, was granted a three-year accreditation by the Intersocietal Accreditation Commission (IAC) in Adult Transthoracic Echocardiography, highlighting its commitment to high-quality patient care. Additionally, Mayo Clinic, with facilities in Arizona, Florida, and Minnesota, performs over 75,000 echocardiograms annually, further underscoring North America's leadership in echocardiography services and innovation. These prestigious institutions enhance the regional market’s growth and reputation in the medical imaging field.
Intracardiac Echocardiography Market: Key Takeaways
Increasing Demand for Minimally Invasive Procedures
The growing preference for minimally invasive procedures is significantly shaping the medical field. According to the American Society of Plastic Surgeons 2023 Procedural Statistics Report, minimally invasive procedures saw a 7% increase in 2023, surpassing traditional surgical procedures by 2%. Popular treatments such as neuromodulator injections and hyaluronic acid fillers contributed to this growth, with more than 9 million and 5 million treatments performed, respectively. This trend reflects the increasing demand for less invasive options that offer quicker recovery times and minimal downtime, driving innovation across various healthcare sectors.
For More Queries About "Intracardiac Echocardiography Market " @ https://www.industryarc.com/Research/intracardiac-echocardiography-market-research-800158
AI-enhanced imaging
The integration of AI into medical imaging is becoming a significant trend, enhancing diagnostic precision and efficiency. In October 2024, iCardio.ai, a Los Angeles-based AI startup co-founded by a cardiologist, received FDA approval for its EchoMeasure software, which evaluates echocardiography data. This marks the company’s first FDA approval, building on its collaborations with various healthcare partners. AI-enhanced imaging like this is poised to revolutionize cardiology by improving the accuracy and speed of diagnostics, making it a key driver in the growth of medical imaging technologies.
Scope of the Report:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recent Developments:
• In August 2024, Siemens Healthineers announced that the Food and Drug Administration (FDA) has granted clearance for the ACUSON Origin, a cutting-edge cardiovascular ultrasound system enhanced with artificial intelligence (AI) capabilities. exclusively available with the ACUSON Origin, the new AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter offers advanced imaging for intricate heart procedures.
• In April 2024, FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, announced the launch of its innovative OPIE Transducer for on-pump intracardiac echocardiography (OPIE) used in septal myectomy procedures. Early clinical users of the OPIE transducer will share insights on how the technology enhances the evaluation of ventricular septal thickness by providing real-time imaging visualization.
Intracardiac Echocardiography Market: Competitive Landscape
Key companies profiled in the Intracardiac Echocardiography Market are Abbott Laboratories, Medtronic, Boston Scientific Corporation, Koninklijke Philips N.V., Siemens Healthineers, GE Healthcare, Johnson & Johnson , Stryker Corporation, Conavi Medical Corp., FUJIFILM and others.
Related Reports:
Medical Imaging Software Market - Medical Imaging Software Market Size is forecast to reach $ 13252.4 Million by 2030, at a CAGR of 7.25% during forecast period 2024-2030. Early diagnosis of such a life-threatening disease by screening and the increasing prevalence of various chronic diseases like cancer, arthritis, etc, are majorly responsible for the growing size of the medical imaging software market.
Imaging In Clinical Trials Market - Imaging in Clinical Trials Market size is estimated to reach $1,427 million by 2027, growing at a CAGR of 5.5% during the forecast period 2022-2027. Technological advancements in discovering new drugs and medicines, virus attacks, spending on the healthcare system by the government to tackle upcoming contingencies are set to drive the growth of the Imaging In Clinical Trials Industry.
X-ray Systems Market - The X-ray Systems Market Size is estimated to reach $10.8 billion by 2027 and it is poised to grow at a CAGR of 4.8% over the forecast period of 2022-2027, owing to increasing healthcare demand, the growing geriatric population, healthcare infrastructure development, government initiatives, rising awareness of early diagnosis, and the preference for minimally invasive procedures.
About IndustryARC™:
IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets.
IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.
Contact Us:
lMr. Venkat Reddy
IndustryARC
Email: [email protected]
USA: (+1) 518-282-4727
Web: https://www.industryarc.com
Follow us on LinkedIn | Facebook | Twitter